A two-stage cascade of biomechanical breakdown contributes to corneal ectasia after LASIK and PRK, and mimics the failure process associated with keratoconus. Ectasia after LASIK and PRK was linked ...

KIAWAH ISLAND, S.C. — An effective treatment for corneal ectasia and keratoconus has long eluded ophthalmologists, but a novel therapeutic approach using collagen cross-linking may offer promise, ...

Corneal collagen crosslinking (CXL) is a relatively new technique to reduce the progression of keratoconus. The technique can be performed with or without complete debridement of the corneal ...

Despite its popularity and safety track record, laser in situ keratomileusis (LASIK) remains associated with the rare but significant complication of corneal ectasia. One theoretical advantage of ...

Avedro announced that it has submitted a New Drug Application (NDA) to the FDA for VibeX (riboflavin ophthalmic solution)/KXL System for the treatment of keratoconus and corneal ectasia following ...

Avedro announced that the FDA has granted a second orphan drug designation for VibeX (riboflavin ophthalmic solution) for use with its KXL System (UVA irradiation) for corneal cross-linking to treat ...

The Cornea and Laser Eye Institute, with Principal Investigator, Peter S. Hersh M.D., is conducting a research study to study the safety and effectiveness of corneal collagen crosslinking (CXL) using ...

An advisory panel of the US Food and Drug Administration (FDA) on February 24 recommended approval of a new drug that treats two eye disorders with corneal collagen crosslinking, but waved some yellow ...

Attention deficit-hyperactivity disorder (ADHD) was associated with a diagnosis of keratoconus in males, according to an Israeli population-based cross-sectional study. Looking at the medical records ...